Modern approaches to the treatment of patients with functional constipation
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 4
Abstract
Objective — to study the efficacy and tolerability of the Lactofor® complex (Ananta Medicare) in outpatients with the verified diagnosis of functional constipation (FC) according to Rome criteria IV. Materials and methods. The study involved 30 outpatients with FC aged 33- 59 years (mean age 47.6 ± 5.9 years), with an average disease duration of 14.9 ± 4.8 years, who were treated with the Lactofor® complex during 28 days: the first 5 days — 2 sachets per day, followed by 1 — 2 sachets per day. The treatment effectiveness was assessed by the dynamics of defecation frequency, the feces according the Bristol scale, the assessment of pain syndrome and flatulence on the visual analog scale, the hydrogen breath test (HBT) with lactulose. Patients’ status and quality of life were assessed with the use of specialized patient questionnaires (PAC-SYM — Patient Assessment of Constipation Symptoms and PAC-QoL — Patient Assessment of Quality of Life questionnaire). Results. The administration of Lactofor® complex to patients with FC promoted the increase ofbowel movements’ frequency (after 28 days of observation, 100 % of patients reported daily bowel movement, lack of tension and incomplete emptying) and normalization of stool character, which was confirmed by an increase in stool scores according to the Bristol scale (2.07 ± 0.4 vs 3.42 ± 0.25; p < 0.05). The effects of Lactofor® complex on the reduction of FC symptomshas been established, in particular, a decrease in the intensity and severity of flatulence in 1.9 times (p < 0.01), as well as painful abdominal syndrome in 2.1 times (p < 0.01). There was also a clear positive trend in PAC-SYM and quality of life (PAC-QoL) indicators. Reduction of HBT at all intervals of the test confirmed the positive effect of the Lactofor® complex on reducing the severity of the bacterial overgrowth syndrome. Conclusions. The administrationof Lactofor® complex to patients with FC promoted the increase of bowel movements’ frequency, normalization of stool character, it resulted in the reduction ofintensity and severity of flatulence, painful abdominal syndrome, as well as improvement of the quality of life.
Authors and Affiliations
I. M. Skrypnyk, O. F. Gopko, I. G. Kryvoruchko
Keywords
Related Articles
- EP ID EP670162
- DOI 10.30978/MG-2019-4-85
- Views 123
- Downloads 0
Hyperplastic polyps, serrated adenomas — relevance of the topic, classification, morphological signs and risks of colorectal carcinoma
The paper present the proof for risks of the rectal carcinoma developing from the serrated polyps, adenomas. The histological structure of these tumors is typical, therefore, they should be morphologically verified. The...
The place of domperidone in the treatment of comorbid pathology of esophagus and stomach (a clinical case)
It has been established that around 20 % of patients with gastroesophageal reflux disease (GERD) have clinical symptoms of the functional gastric dyspepsia, and 20 — 30 % of patients with predominantly non-erosive reflux...
The relationship of serum inflammatory markers with metabolic disorders at the non-alcoholic fatty liver disease
Objective — to study the serum levels of proinflammatory markers and determine their role in the formation of metabolic disorders in patients with non-alcoholic fatty liver disease (NAFLD). Materials and methods. Examin...
Functional dyspepsia: diagnostic and therapeutic options
Objective — to study the effects of digestive enzymes on the symptoms of functional dyspepsia FD and the state of gastric motility. Materials and methods. Observations involved 60 patients with FD (21 men and 39 women,...
Pathogenetic role of visceral adipose tissue in the development of non-alcoholic fatty liver disease in patients with metabolic syndrome
Objective — to study the nature of changes in carbohydrate and lipid metabolism, depending on the distribution and activity of visceral adipose tissue (VAT), and the degree of liver steatosis in patients with nonalcoholi...